CHOLESTATIC LIVER DISEASES

Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
Lijun Liao, Kai Markus Schneider, Eric J C Galvez, Mick Frissen, Hanns-Ulrich Marschall, Huan Su, Maximilian Hatting, Annika Wahlström, Johannes Haybaeck, Philip Puchas, Antje Mohs, Jin Peng, Ina Bergheim, Anika Nier, Julia Hennings, Johanna Reißing, Henning W Zimmermann, Thomas Longerich, Till Strowig, Christian Liedtke, Francisco J Cubero, Christian Trautwein

Gut Aug 2019, 68 (8) 1477-1492; DOI: 10.1136/gutjnl-2018-316670
Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
Christian Rupp, Theresa Hippchen, Thomas Bruckner, Petra Klöters-Plachky, Anja Schaible, Ronald Koschny, Adolf Stiehl, Daniel Nils Gotthardt, Peter Sauer

Gut Mar 2019, gutjnl-2018-316801; DOI: 10.1136/gutjnl-2018-316801
Oesophageal and scaly skin lesions associated with chronic cholestatic liver disease
Philipp Kasper, Tobias Goeser, Dirk Nierhoff

Gut Mar 2019, gutjnl-2019-318502; DOI: 10.1136/gutjnl-2019-318502
Manipulation of the gut–liver axis by interruption of bile acid recirculation: an option for the treatment of sclerosing cholangitis?
Daniel Jahn, Marco Marzioni, Andreas Geier

Gut Sep 2018, 67 (9) 1565-1567; DOI: 10.1136/gutjnl-2018-316375
Response to ‘Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis’ by Rühlemann et al
Martin Kummen, Johannes R Hov

Gut Apr 2017, 66 (4) 755-756; DOI: 10.1136/gutjnl-2016-312347
Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis
Malte Christoph Rühlemann, Femke-Anouska Heinsen, Roman Zenouzi, Wolfgang Lieb, Andre Franke, Christoph Schramm

Gut Apr 2017, 66 (4) 753-754; DOI: 10.1136/gutjnl-2016-312180
Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches
Gregory A Michelotti, Anikia Tucker, Marzena Swiderska-Syn, Mariana Verdelho Machado, Steve S Choi, Leandi Kruger, Erik Soderblom, J Will Thompson, Meredith Mayer-Salman, Heather A Himburg, Cynthia A Moylan, Cynthia D Guy, Katherine S Garman, Richard T Premont, John P Chute, Anna Mae Diehl

Gut Apr 2016, 65 (4) 683-692; DOI: 10.1136/gutjnl-2014-308176
Targeting TGR5 in cholangiocyte proliferation: default topic
Cecília M P Rodrigues, Han Moshage

Gut Mar 2016, 65 (3) 369-370; DOI: 10.1136/gutjnl-2015-310812
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study
Palak J Trivedi, Willem J Lammers, Henk R van Buuren, Albert Parés, Annarosa Floreani, Harry L A Janssen, Pietro Invernizzi, Pier Maria Battezzati, Cyriel Y Ponsioen, Christophe Corpechot, Raoul Poupon, Marlyn J Mayo, Andrew K Burroughs, Frederik Nevens, Andrew L Mason, Kris V Kowdley, Ana Lleo, Llorenç Caballeria, Keith D Lindor, Bettina E Hansen, Gideon M Hirschfield

Gut Feb 2016, 65 (2) 321-329; DOI: 10.1136/gutjnl-2014-308351
Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity
Raquel Gordo-Gilart, Sara Andueza, Loreto Hierro, Pilar Martínez-Fernández, Daniel D'Agostino, Paloma Jara, Luis Alvarez

Gut Jan 2015, 64 (1) 147-155; DOI: 10.1136/gutjnl-2014-306896

Main menu

CHOLESTATIC LIVER DISEASES

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

CHOLESTATIC LIVER DISEASES

Pages